The U.S. Food and Drug Administration (FDA) has issued an early alert regarding malfunctioning glucose monitors from Abbott Diabetes Care, which may be linked to seven deaths and over 700 serious injuries. The alert concerns the FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors, which may provide incorrect low glucose readings. This issue affects about three million devices, traced back to a single production line.

According to the FDA, these incorrect readings can lead to improper diabetes management , such as excessive carbohydrate intake or delayed insulin doses, posing serious health risks, including potential injury or death. The FDA's alert, issued on Tuesday (December 2), advises users to immediately stop using the affected sensors and dispose of them.

Abbott Diabetes Care

See Full Page